In particular, our data suggest that LINC01605 is a novel lncRNA directly regulated by mut_p53, involved in mut_p53-dependent increased cell invasion and motility in MDA-MB-231 cells and likely involved in cancer cell aggressiveness, since breast cancer patients with higher LINC01605 expression levels display a worse outcome. This evidence concerns the gene TP53 and breast carcinoma.